Failure Of Lilly Drug Is Latest Alzheimer's Setback

It's the latest setback in a field marked by failure. Earlier this month, Pfizer and Johnson & Johnson said they were dropping development of a similar experimental drug after big clinical studies showed it wasn't working.

medical centers in seattle